Annual Total Long Term Liabilities
$325.00 K
-$451.00 K-58.12%
December 31, 2023
Summary
- As of February 8, 2025, AVTE annual total long term liabilities is $325.00 thousand, with the most recent change of -$451.00 thousand (-58.12%) on December 31, 2023.
- During the last 3 years, AVTE annual total long term liabilities has fallen by -$15.96 million (-98.00%).
- AVTE annual total long term liabilities is now -98.00% below its all-time high of $16.29 million, reached on December 31, 2020.
Performance
AVTE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$151.00 K
-$125.00 K-45.29%
September 30, 2024
Summary
- As of February 8, 2025, AVTE quarterly total long term liabilities is $151.00 thousand, with the most recent change of -$125.00 thousand (-45.29%) on September 30, 2024.
- Over the past year, AVTE quarterly long term liabilities has dropped by -$174.00 thousand (-53.54%).
- AVTE quarterly long term liabilities is now -99.81% below its all-time high of $79.82 million, reached on June 30, 2021.
Performance
AVTE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AVTE Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.1% | -53.5% |
| 3 y3 years | -98.0% | -53.5% |
| 5 y5 years | -95.0% | -53.5% |
AVTE Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -58.1% | at low | -82.7% | at low |
| 5 y | 5-year | -98.0% | at low | -99.8% | at low |
| alltime | all time | -98.0% | at low | -99.8% | at low |
Aerovate Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $151.00 K(-45.3%) |
| Jun 2024 | - | $276.00 K(-30.8%) |
| Mar 2024 | - | $399.00 K(+22.8%) |
| Dec 2023 | $325.00 K(-58.1%) | $325.00 K(-24.1%) |
| Sep 2023 | - | $428.00 K(-21.5%) |
| Jun 2023 | - | $545.00 K(-17.5%) |
| Mar 2023 | - | $661.00 K(-14.8%) |
| Dec 2022 | $776.00 K | $776.00 K(-4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $813.00 K(-7.1%) |
| Jun 2022 | - | $875.00 K(+150.7%) |
| Mar 2022 | - | $349.00 K(-11.6%) |
| Dec 2021 | $395.00 K(-97.6%) | $395.00 K(-12.6%) |
| Sep 2021 | - | $452.00 K(-99.4%) |
| Jun 2021 | - | $79.82 M(+228.7%) |
| Mar 2021 | - | $24.28 M(+49.1%) |
| Dec 2020 | $16.29 M(+150.5%) | $16.29 M |
| Dec 2019 | $6.50 M | - |
FAQ
- What is Aerovate Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual total long term liabilities year-on-year change?
- What is Aerovate Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly long term liabilities year-on-year change?
What is Aerovate Therapeutics annual total long term liabilities?
The current annual total long term liabilities of AVTE is $325.00 K
What is the all time high annual total long term liabilities for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual total long term liabilities is $16.29 M
What is Aerovate Therapeutics annual total long term liabilities year-on-year change?
Over the past year, AVTE annual total long term liabilities has changed by -$451.00 K (-58.12%)
What is Aerovate Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of AVTE is $151.00 K
What is the all time high quarterly long term liabilities for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly total long term liabilities is $79.82 M
What is Aerovate Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, AVTE quarterly total long term liabilities has changed by -$174.00 K (-53.54%)